Compliance review: Sun Pharma’s Halol plant gets 8 USFDA...

Dununu.com Dununu

Patrocinado

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

RSS Feed Business

Postado

118

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.

Read Full Article

Faça Login para curtir, compartilhar e comentar!

'Objectionable language': Karan Aujla, Honey Singh summoned; Punjab women's panel flags songs

Por 0 1

NIACL AO result 2025 out at newindia.co.in: Check direct link to download scorecards for prelims, mains, and interview here

Por 0 4

Nepal exports over Rs 17.5 billion worth of electricity to India and Bangladesh

KATHMANDU: Nepal has exported over Rs 1.75 billion worth of electricity to India and Bangladesh...

Por 0 4

Trade war: US tariffs on India may hurt manufacturing, labour-intensive sectors; experts warn of wider economic impact

Experts caution that the recent 50% U.S. tariffs on Indian imports pose a significant threat to...

Por 0 8

NC General Secretary objects EC’s party self-assessment draft

KATHMANDU: Nepali Congress General Secretary Bishwa Prakash Sharma has expressed strong...

Por 0 16